Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Convocation Keynote Encourages Students to Recognize Power They Have to Influence Others

October 2, 2014 – 6:00 am | Edit Post

Mahatma Gandhi had a saying that he used to mobilize millions of poor people in India to gain independence: “You must be the change you wish to see in the world.”

Diabetes in a Dish

October 1, 2014 – 2:27 pm | Edit Post

Researchers at University of California, San Diego School of Medicine are co-recipients of a $4.1-million grant from the National Institutes of Health to advance treatments for type 1 diabetes. Using human stem cells, the team plans to culture bits of human pancreas in a dish and, using microfluidics, mimic blood flow through the islet.

Health Care and Construction Workers Create Pink Ribbon For Breast Cancer Awareness

September 30, 2014 – 1:55 pm | Edit Post

More than 600 health care and construction workers donned pink hard hats while forming a giant human ribbon at the UC San Diego Jacobs Medical Center construction site today in support of National Breast Cancer Awareness month.

Phase III Clinical Trial to Evaluate Calcium Channel Blocker for Parkinson’s

September 30, 2014 – 10:36 am | Edit Post

Phase III Clinical Trial to Evaluate Calcium Channel Blocker for Parkinson’s

Researchers at the University of California, San Diego School of Medicine have launched a Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease. The goal of the study is to determine whether the drug can slow the progression of the disease by keeping the brain’s dopamine-producing cells healthier for a longer period of time.

A signature for early-stage heart failure could improve diagnosis and prevent disease progression

September 30, 2014 – 8:53 am | Edit Post

Metabolic signature identifies early heart failure in mice.

ZMapp Ebola Drug Production Set for Texas, Possibly North Carolina

September 30, 2014 – 5:00 am | Edit Post

A federal initiative to ensure that the United States can respond to biological threats at home will be put to the test in response to the Ebola outbreak in West Africa. A Texas site is preparing to…

[[Click headline to continue reading.]]

Salk scientists receive $3 million for BRAIN Initiative grant

September 29, 2014 – 5:00 pm | Edit Post

LA JOLLA—Joseph Ecker, a Salk professor and Howard Hughes Medical Institute investigator, and Margarita Behrens, Salk staff scientist, have been named recipients in the 2014 round of grants from the National Institutes of Health (NIH) through the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative for leading-edge work in neuroscience. The grant, announced September 30, provides more than $3 million in funding to the Salk scientists over three years.

A “Frenemy” in Parkinson’s Disease Takes to Crowdsourcing

September 29, 2014 – 1:53 pm | Edit Post

Researchers have found that a key neuronal protein called alpha-synuclein normally gathers in synapses, where aggregates of it help regulate neurotransmissions. In overabundance, though, a-synuclein can choke off communication altogether, leading to neuronal death and related diseases.

New insights into how the heart forms may help identify heart defects

September 29, 2014 – 11:22 am | Edit Post

Cdc42 controls embryonic heart formation.

Daiichi Sankyo Offers $315M Up Front to Get Ambit and Leukemia Drug

September 29, 2014 – 10:09 am | Edit Post

Japan’s Daiichi Sankyo has agreed to acquire San Diego cancer drug developer Ambit Biosciences (NASDAQ: AMBI) for $315 million in cash, with additional milestone payments that could bring the total…
[[Click headline to continue reading.]]